Are you Dr. Knapp?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 51 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3100 Plaza Properties Blvd
Columbus, OH 43219Phone+1 614-383-6000Fax+1 614-383-6001- Is this information wrong?
Summary
- Dr. Mark Knapp, MD is an oncologist in Columbus, Ohio. He is currently licensed to practice medicine in Ohio and Kentucky. He is affiliated with Mount Carmel West, OhioHealth Grady Memorial Hospital, and Madison Health.
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2000 - 2003
St Vincent Hospital and Health Care CenterResidency, Internal Medicine, 1997 - 2000
University of Cincinnati College of MedicineClass of 1997
Certifications & Licensure
OH State Medical License 2000 - 2024
KY State Medical License 2001 - 2002- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) Start of enrollment: 2013 Aug 01
- A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
- Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2014 Mar 13
Publications & Presentations
PubMed
- 18 citationsThe combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma.Nathan Fowler, Loretta J. Nastoupil, Sven de Vos, Mark Knapp, Ian W. Flinn, Robert T. Chen, Ranjana H. Advani, Sumeet Bhatia, Peter Martin, Raul Mena, Richard E. Davis...> ;British Journal of Haematology. 2020 Mar 16
- 88 citationsIbrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non-germinal center B-cell-like DLBCLAndre Goy, Radhakrishnan Ramchandren, Nilanjan Ghosh, Javier Munoz, David S. Morgan, Nam H. Dang, Mark Knapp, Maria Delioukina, Edwin C. Kingsley, Jerry Ping, Darrin M...> ;Blood. 2019 Sep 26
- 5 citationsIntensity modulated radiation therapy with simultaneous integrated boost based dose escalation on neoadjuvant chemoradiation therapy for locally advanced distal esopha...Ming Zeng, Fernando N Aguila, Taral Patel, Mark Knapp, Xue-Qiang Zhu, Xi-Lin Chen, Phillip D Price> ;World Journal of Gastrointestinal Oncology. 2016 May 15
Hospital Affiliations
- OhioHealth Grady Memorial HospitalDelaware, Ohio
- Madison HealthLondon, Ohio
Mount Carmel WestColumbus, Ohio
